Overexpression of SOCS3 is associated with decreased survival in a cohort of patients with de novo follicular lymphoma

British Journal of Haematology

Volumn 135, Issue 1, 2006, Pages 72-75

  Krishnadasan, Ravitharan ^a   Bifulco, Carlo ^a   Kim, Julie ^a   Rodov, Sofya ^a   Zieske, Arthur W ^a   Vanasse, Gary J ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Cytokine; Follicular lymphoma; Prognostic factor; Survival

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN BCL 2; SUPPRESSOR OF CYTOKINE SIGNALING 3;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 33748343624     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06248.x     Document Type: Article

References (12)

1. Alexander, W.S. & Hilton, D.J. (2004) The role of cytokine signaling (SOCS) proteins in regulation of the immune response. Annual Reviews in Immunology, 22, 503-529.
2. H on Chromosome 14 and near a transcriptional unit on 18. Cell, 41, 899-906.
3. Dave, S.S., Wright, G., Tan, B., Rosenwald, A., Gascoyne, R.D., Chan, W.C., Fisher, R.I., Braziel, R.M., Rimsza, L.M., Grogan, T.M., Miller, T.P., LeBlanc, M., Greiner, T.C., Weisenburger, D.D., Lynch, J.C., Vose, J., Armitage, J.O., Smeland, E.B., Kvaloy, S., Holte, H., Delabie, J., Connors, J.M., Lansdorp, P.M., Ouyang, Q., Lister, T.A., Davies, A.J., Norton, A.J., Muller-Hermelink, H.K., Ott, G., Campo, E., Montserrat, E., Wilson, W.H., Jaffe, E.S., Simon, R., Yang, L., Powell, J., Zhao, H., Goldschmidt, N., Chiorazzi, M. & Staudt, L.M. (2004) Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. New England Journal of Medicine, 351, 2159-2169.
4. Horning, S.J. (2000) Follicular lymphoma: have we made any progress? Annals of Oncology, 11, Suppl. 1, 23-27.
5. Jaffe, E.S., Harris, N.L., Stein, H. & Wardiman, J.W. (2001) WHO Classification of Tumours. Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon.
6. Kluger, H.M., Dolled-Filhart, M., Rodov, S., Kacinski, B.M., Camp, R.L. & Rimm, D.L. (2004) Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis. Clinical Cancer Research, 10, 173-177.
7. Limpens, J., Stad, R., Vos, C., de Vlaam, C., de Jong, D., van Ommen, G.J.B., Schuuring, E. & Kluin, P.M. (1995) Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood, 85, 2528-2536.
8. McDonnell, T.J. & Korsmeyer, S.J. (1991) Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14:18). Nature, 349, 254-256.
9. Solal-Celigny, P., Roy, P., Colombat, P., White, J., Armitage, J.O., Arranz-Saez, R., Au, W.Y., Bellei, M., Brice, P., Caballero, D., Coiffier, B., Conde-Garcia, E., Doyen, C., Federico, M., Fisher, R.I., Garcia-Conde, J.F., Guglielmi, C., Hagenbeek, A., Haioun, C., LeBlanc, M., Lister, A.T., Lopez-Guillermo, A., McLaughlin, P., Milpied, N., Morel, P., Mounier, N., Proctor, S.J., Rohatiner, A., Smith, P., Soubeyran, P., Tilly, H., Vitolo, U., Zinzani, P.L., Zucca, E. & Montserrat, E. (2004) Follicular lymphoma international prognostic index. Blood, 104, 1258-1265.
10. Starr, R., Willson, T.A., Viney, E.M., Murray, L.J., Rayner, J.R., Jenkins, B.J., Gonda, T.J., Alexander, W.S., Metcalf, D., Nicola, N.A. & Hilton, D.J. (1997) A family of cytokine-inducible inhibitors of signalling. Nature, 387, 917-921.
11. Tsujimoto, Y., Gorham, J., Cossman, J., Jaffe, E. & Croce, C.M. (1985) The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science, 22, 1390-1393.
12. Vanasse, G.J., Winn, R.K., Rodov, S., Zieske, A.W., Li, J.T., Tupper, J.C., Tang, J., Raines, E.W., Peters, M.A., Yeung, K,Y. & Harlan, J.M. (2004) Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma. Molecular Cancer Research, 2, 620-631.